Improving cancer research with optimized targeted NGS workflows

In this article, Roche demonstrates how their KAPA HyperPETE workflow can provide improved targeted next-generation sequencing (NGS), and thereby provide strong therapeutic prospects for cancerresearch.

Related Keywords

Brian Godwin ,Nitya Furtado ,Mariana Fitarelli Kiehl ,Jimmy Tu ,Spencer Debenport ,Mingyang Cai ,Arjun Kumar ,Jingchuan Li ,Roche Sequencing Solutions ,National Cancer Institute ,Roche Diagnostics ,Roche Pharmaceuticals ,Agilent Technologies ,Library Preparation ,Hyperpete Primer Extension Target Enrichment Technology ,Roche Diagnostics Corporation ,Sponsored Content ,Roche Diagnostics Limitedmar ,Primer Extension Target Enrichment ,Mutation Caller ,Somatic Tissue ,Prep Kit ,Plus Kit ,Extension Target Enrichment ,Thermo Fisher Scientific ,High Sensitivity ,Target Enrichment ,Unique Molecular ,Image Credit ,Workflow Instructions ,Thigh Pure ,Kit Instructions ,Florence Crary Dooley Senior Scientist ,Roche Molecular Labs ,Content Policy ,News Medical Net ,Cancer ,Bags ,